Unique Clinical Pearl sessions are held throughout the AAPP Annual Meeting. Slide sets for these sessions are made available through the AAPP Communities.

2022 Annual Meeting

  • Cusimano J. Parkinsonism-hyperpyrexia Syndrome. [Weblink]
  • Doroudgar S. Antipsychotic-Induced Hyperprolactinemia: An Approach to Medication Management. [Weblink]
  • Liriano C. Clozapine: Removing the Smoke Screen. [Weblink]

2021 Annual Meeting

  • Cusimano J. Phenibut Withdrawal. [Weblink]
  • Hahn N. Folic Acid Supplementation in Women with Epilepsy on Antiepileptic Drug(s). [Weblink]
  • Shuman M. Morbid Obesity: Implications for the Psychiatric Patient (and Practitioner). [Weblink]

2020 Annual Meeting

  • Barlow G. Acute Pain Management and Buprenorphine: A Paradigm Shift. [Weblink]
  • Brockbank J. Pre-Exposure Prophylaxis for HIV: A Primer for Psychiatric Pharmacists. [Weblink]
  • Davis E. Haloperidol as Non-opioid Alternative for Chronic Abdominal Pain/Headache in the Emergency Department. [Weblink]
  • Ehret M. Development of an Esketamine Administration Clinic. [Weblink]
  • Hampton C. The Cannabis Analysis: Discussing Common Contaminants in Cannabidiol-Related Products. [Weblink]
  • Pals H. Unexpected Consequences of Medication Misuse: Robotripping into Bromism. [Weblink]

2019 Annual Meeting

    • Moreno J. Hot Take: PRN Anxiolytics Might Cause More Harm than Good. [Weblink]
    • Colvard M. Double Trouble: Management of Concurrent Opioid and Alcohol or Benzodiazepine Withdrawal. [Weblink]
    • Carr C. Adjunct Allopurinol for the Treatment of Schizophrenia and Aggression. [Weblink]
    • Davis E. Clozapine-Associated Renal Failure. [Weblink]

    2018 Annual Meeting

    • Burke B. Psychotropics and Priapism: A Painful, Personal Problem. [Weblink]
    • Khorassani F. Antipsychotic Drug Selection with Cobicistat-Containing Antiretroviral Regimens. [Weblink]
    • Harris S. Catatonia Following Organ Transplant: Beyond Benzodiazepines or ECT. [Weblink]

    2017 Annual Meeting

    • Phan S. Cannabis Hyperemesis Syndrome. [Weblink]
    • Su MA. Is Mirtazapine a Treatment for Akathisia? [Weblink]
    • Campbell A. Clozapine Re-challenge after NMS and Seizures in a Patient with DiGeorge. [Weblink]
    • McKee J. The Value of Collaborating/Considering Community Pharmacists as Part of the Clinical Team Supporting Persons with Serious and Persistent Mental Illness. [Weblink]
    • Farinde A. Association between Pisa Syndrome (Pleurothonus), Psychoactive Medications, and Cholinesterase Inhibitors. [Weblink]
    • Finocchio B. Medication Selection in Correctional Populations. [Weblink]
    • Kral L. Why Glial Cells Hurt - Talking to Patients About Chronic Pain. [Weblink]
    • Weisser L. More than Genotype: Including Concurrent Medications and Environmental Factors in Phenotype Analysis for Pharmacogenomic Recommendations. [Weblink]

    2016 Annual Meeting

    • Harris SC. Lamotrigine Rash in Refractory Bipolar Depression - When is Continuation, Discontinuation, or Rechallenge Warranted? [Weblink]
    • Boggie D. Management of Psychosis in Anti-NMDA Receptor Encephalitis. [Weblink]
    • Wright EA. Beta Blockers for Behavioral and Psychological Symptoms of Dementia. [Weblink]
    • DeJongh B. Morgellons Disease - Delusional Parasitosis or Unexplained Dermopathy? [Weblink]

    2015 Annual Meeting

    • Finocchio B. Adjunctive Estrogen Therapy in Schizophrenia. [Weblink]
    • Garris SS. Use of Zolpidem for Catatonia. [Weblink]
    • Lister J. Treatment Options for Clozapine-Induced Dyscrasias. [Weblink]
    • Richardson K. The Danger Zone: Where Benzodiazepines and Opiates Meet. [Weblink]

    2014 Annual Meeting

    • Dishman B. Thiamine Deficiency Can Be Berberi Bad. [Weblink]
    • Gonzalez ML. Use of Vitamin B6 to Treat Patients with Tardive Dyskinesia. [Weblink]
    • Mullen S. Pseudobulbar Affect in a 14 Year-Old Adolescent. [Weblink]

    2013 Annual Meeting

    • Cobb CD, Dopheide JA, McKee JR. Implementing Comprehensive Medication Management for Patients with Mental Illness. [Weblink]
    • Cunningham JL. Opioid Induced Hyperalgesia: Can Opioids Worsen Pain? [Weblink]
    • Dishman B. PTSD and Sleep: Prazosin Alone is Not Always the Answer. [Weblink]
    • Allen SN. Don't Forget: Urea Cycle Disorder. [Weblink]
    • Schneiderhan ME. Electronic Cigarettes and Smoking Cessation. [Weblink]

    2012 Annual Meeting

    • Ayala A. Twice a day dosing of Aripiprazole. [Weblink]
    • Canning JE. Central Anticholinergic Syndrome. [Weblink]
    • Kennedy LH. Clozapine-induced Myocarditis. [Weblink]
    • Winistoerfer N. Levamisole-Induced Vasculitis with Necrosis in Cocaine Users. [Weblink]

    2011 Annual Meeting

    • Breden EL. Unique Side Effects of Olanzapine. [Weblink]
    • Caley CF. Influence of CYP Genotyping on Psychiatric Pharmacist Consultations.  [Weblink]
    • Fowler JA. Clozapine-Induced Gastrointestinal Hypomotility: More Than Just Constipation. [Weblink]
    • Nelson JL. The Misuse/Abuse of Psychiatric Medications in the Correctional Healthcare Setting. [Weblink]

    2010 Annual Meeting

    • Nelson JL. Making a Good Connection: The Impact on Patient Care. [Weblink]
    • Popish SJ and Perry P. Anabolic Steroid Rage. [Weblink]
    • Price PL. Impacting Lives in Forensic Pharmacy: The Literature is Your Friend. [Weblink]
    • Purvis TL. What One Case of Severe EPS Can Teach You. [Weblink]
    Reviewer 1: Katelynn Mayberry, PharmD
    Reviewer 2: Caitlin Christman, PharmD
    Reviewer 3: Joseph M. Cusimano, PharmD, BCPP
    2022-2023 AAPP Resident and New Practitioner Committee